While numerous countries are confronting dengue fever outbreaks in 2024, with over 11 million cases in the Region of the Americas, there is a pending shift in accessing preventive vaccines.
As of early August 2024, the World Health Organization recommends using a second-generation dengue vaccine: Takeda's QDENGA vaccine. However, there is overwhelming demand, surpassing current vaccine production capabilities.
Read More
